23 July 2021

GSK Stockmann advises two investors within the framework of the upcoming HomeToGo Listing

GSK Stockmann advises PG HoldCo and Princeville Capital, investors in the Berlin-based travel start-up HomeToGo, in relation to the planned listing via a SPAC structure on the Frankfurt Stock Exchange.

HomeToGo is an online marketplace for vacation rentals and plans to go public on the Frankfurt Stock Exchange via the stock exchange shell company Lakestar SPAC I SE. The transaction is the first signed European De-SPAC with a German target, which – supplemented by a capital increase – will provide HomeToGo with approximately €350 million fresh money to expand its global presence. PG HoldCo and venture capital investment firm Princeville Capital, both based in the U.S., are among the current shareholders of HomeToGo, who hold shares in the vacation rental brokerage company that will be listed on the stock exchange in future. PG HoldCo, together with GSK Stockmann, has already sold its US competitor Tripping International, Inc. to HomeToGo in 2018. Princeville Capital, who have already worked with Katy Ritzmann within the framework of their initial investment in HomeToGo, is again being represented by the proven team in this capital market transaction following good experience in connection with the IPO of Auto1 Group SE earlier this year.

Under the leadership of partner Dr. Katy Ritzmann, GSK Stockmann is advising the investors on all issues relating to the Business Combination Agreement as well as tax matters relating to the listing which is planned for September via the SPAC structure.

Adviser PG HoldCo and Princeville Capital

GSK Stockmann: Katy Ritzmann (VC, lead), Heiko Stoll and Mathilde Ostertag (both Tax

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Dr. Katy Ritzmann

Partner*

+49 30 203907-422

katy.ritzmann@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral